department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE · pharmadog

pharmadog
drugs
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

drug

patient view →

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

updated 2mo ago

by MSN Pharmaceuticals Inc

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

generic

LINAGLIPTIN

Data sources

ClinicalTrials.gov

last refreshed 24m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval24 co-mentions · 8 sources
drugLINAGLIPTIN20 co-mentions · 8 sources
tagSmall Molecule12 co-mentions · 8 sources
drugmetformin hydrochloride SR8 co-mentions · 4 sources
drugSITAGLIPTIN AND METFORMIN HYDROCHLORIDE8 co-mentions · 4 sources
drugmetformin8 co-mentions · 4 sources
drugmetformin hydrochloride8 co-mentions · 4 sources
drugmetformin hydrochloride ER8 co-mentions · 4 sources

Trials studying LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

phase4Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combinationrecruitingn=800
phase4Glycemic Variability of Combination Therapies in T2DMrecruitingn=178
phase2A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)completedn=214
phase2A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)completedn=314
phase3Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitusrecruitingn=270
phase1Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tabletscompletedn=14
—Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellituscompletedn=1,053
phase1To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.completedn=40

more trials →